Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Viral Clearance Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The viral clearance market has experienced swift expansion over recent years. Between 2025 and 2026, its valuation is projected to rise from $0.96 billion to $1.12 billion, reflecting a compound annual growth rate (CAGR) of 16.7%. This historic growth was driven by factors such as the limited availability of viral clearance technologies, heightened concerns over viral contamination in biologics, reliance on traditional filtration approaches, increased regulatory oversight, and the broadening of pharmaceutical and biotechnology manufacturing pipelines.
The market for viral clearance is projected to experience strong expansion in the coming years, reaching a value of $2.06 billion by 2030, with a compound annual growth rate (CAGR) of 16.4%. This upward trajectory is fueled by the development of next-generation viral inactivation techniques, a growing reliance on nanofiltration and membrane chromatography, increased production of biologics and gene therapies, the incorporation of automation into viral clearance processes, and heightened investment in the creation of viral detection assays. Key trends shaping the future include a shift toward more sophisticated viral detection and inactivation strategies, a heightened need for safe, virus-free vaccines and therapeutics, the growth of cell and gene therapy products that demand rigorous viral clearance, the adoption of high-efficiency filtration and nanofiltration systems, and a rise in outsourcing to contract research organizations for specialized viral clearance services.
Download A Free Sample Report For Comprehensive Market Insights:
Viral Clearance Market Growth Drivers: What Factors Are Accelerating Expansion?
The anticipated increase in the viral clearance market is set to be fueled by the growing incidence of chronic diseases. These conditions are long-term medical issues that evolve over time and persist for months or years, frequently demanding ongoing treatment or supervision. Worldwide, the frequency of chronic diseases is climbing, and this is mainly attributed to aging populations, as advancements in healthcare and living standards allow people to live longer, thereby elevating the rate of age-linked ailments like cardiovascular diseases, diabetes, arthritis, and cancer. The process of viral clearance plays a vital role in creating biologics and gene therapies that are employed to address chronic diseases, safeguarding their safety and efficacy. As an example, in June 2023, the Institute for Health Metrics and Evaluation—a public health research organization based in the US—disclosed that over 500 million individuals across the globe were suffering from diabetes. This figure is predicted to surge past the 1.3 billion mark by 2050. Hence, the expansion of the viral clearance market is being propelled by the escalating prevalence of chronic diseases.
Viral Clearance Market Segments: Where Are The Largest Growth Opportunities?
The viral clearance market covered in this report is segmented –
1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method
2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users
Subsegments:
1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration
2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography
3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment
4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)
Viral Clearance Market Trends: What Is Shaping Future Industry Growth?
Leading players in the viral clearance market are concentrating their efforts on creating next-generation virus removal filters, which represent a significant advancement in filtration technology designed to boost viral safety and streamline biopharmaceutical production. These enhanced filters are specialized devices engineered to effectively extract viruses from biopharmaceutical products, thereby guaranteeing product integrity, accelerating filtration processes, and facilitating greater output in drug manufacturing operations. In a notable example from October 2024, Asahi Kasei Medical Co., Ltd., a bioprocess and medical solutions firm headquartered in Japan, unveiled its new Planova FG1 virus-removal filter. This filter achieves approximately seven times higher flux compared to the Planova BioEX model, resulting in shortened filtration durations, diminished virus breakthrough possibilities, and consistent performance in protein and virus elimination without needing a prefilter. Additionally, the FG1 is engineered for compatibility with standard CIP/SIP procedures and was put into mass production initially in smaller sizes, with larger versions in development to accommodate scaling needs, offering biomanufacturers higher throughput and quicker cycle times.
Viral Clearance Market Major Participants And Competitive Dynamics
Major companies operating in the viral clearance market are Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Nelson Labs, Pall Corporation, Sartorius AG, Creative Biolabs, Texcell SA, Vironova AB.
Access The Complete Viral Clearance Market Report:
Viral Clearance Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the viral clearance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model